Aurora Cannabis Inc. (ACB) vs Aquestive Therapeutics, Inc. (AQST)

Aurora Cannabis Inc. and Aquestive Therapeutics, Inc. are both Drug Manufacturers Specialty & Generic companies. Aquestive Therapeutics, Inc. is the larger, with a market value of $460.0M against $341.2M — 1.3× the size. Aquestive Therapeutics, Inc. grew revenue faster over the last twelve months: 12.5% against −18.2%. Aurora Cannabis Inc. has the higher net margin (−38.1% vs −162.3%) and the lower return on invested capital (−5.58% vs 0.00%). Across the 17 metrics below, Aquestive Therapeutics, Inc. leads on 10 and Aurora Cannabis Inc. on 7.

Valuation

Metric ACB AQST Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 1.53 9.36 2.08
P/B 0.84 n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 1.28 8.55 2.87
Earnings yield (27.12%) (17.62%) (15.94%)
Free cash flow yield (11.26%) (8.90%) 0.00%

Profitability

Metric ACB AQST Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 65.34% 53.51%
Operating margin (12.13%) (114.12%) 0.00%
Net margin (38.12%) (162.33%) (2.45%)
Free cash flow margin (17.19%) (83.33%) 0.00%
Return on equity (19.85%) 211.59% (0.80%)
Return on assets (15.19%) (56.05%) (1.67%)
Return on invested capital (5.58%) 0.00% 0.00%

Growth

Metric ACB AQST Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) 12.54% 5.22%
EPS growth (last fiscal year) (5,266.67%) (52.94%) 42.91%
Revenue growth, 5-year CAGR 3.92% (0.58%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACB AQST Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 (0.72) 0.04
Current ratio 5.36 6.12 2.41
Net debt to EBITDA 5.11 1.57 1.01

Dividend

Metric ACB AQST Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ACB AQST Drug Manufacturers Specialty & Generic median
Market cap 341.19m 460.01m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack